The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

Diabet MedPublished Retrospective cohort study

Main finding · In-hospital deathResult — go to the resultOdds ratio 1.178 95% CI 1.168–1.188

Authors' conclusion

Diabetes mellitus is an independent predictor of worse outcomes in hospitalized people with COVID-19 in Brazil. Mortality is strongly influenced by age, co-morbidities and severity markers, while vaccination provides substantial protection.

Study context

Population
People hospitalized with SARS-CoV-2 in Brazil, March 2020 to March 2024
Participants
2,078,062 people
Exposure
DM vs no DM among people hospitalized with COVID-19
  • DMn = 461,647
Outcome
Risk of in-hospital death and likelihood of classification as DM
Methodological detailsnationwide registry data (Open-Data-SUS), multivariable logistic regression
  • Nationwide registry data (Open-Data-SUS)
  • Multivariable logistic regression

Main finding

In-hospital death

Odds ratio

1.178

95% CI 1.168–1.188

DMvs No DM
OR 1.178 (95% CI 1.168–1.188)

As reported in the abstract

DM prevalence
22.2%
Overall mortality
32.9%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
ICU admission1.102 (1.093–1.112)
Invasive mechanical ventilation1.102 (1.087–1.118)

Death: other predictors

COVID-19 vaccination, OR for death
0.588 (95% CI 0.583-0.594)
Invasive mechanical ventilation, OR for death
12.933 (95% CI 12.752-13.115)
Age >85 years vs younger groups, OR for death
32.840 (95% CI 30.840-34.969)
Nosocomial infection substantially increased mortality risk

Factors associated with DM

Older age, female sex and self-identification as Black, mixed-race or Asian strongly associated with DM

Original publication

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic. Diabet Med. Published 5 May 2026. doi:10.1111/dme.70349

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.